Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay
Open Access
- 1 June 1994
- Vol. 73 (11) , 2843-2852
- https://doi.org/10.1002/1097-0142(19940601)73:11<2843::aid-cncr2820731130>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.Journal of Clinical Oncology, 1991
- Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryCarcinogenesis: Integrative Cancer Research, 1991
- Characterization of the DNA damage recognized by the antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNACarcinogenesis: Integrative Cancer Research, 1990
- The measurement of cisplatin-DNA adduct levels in testicular cancer patientsCarcinogenesis: Integrative Cancer Research, 1988
- Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.Proceedings of the National Academy of Sciences, 1987
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Chemotherapy for Germ Cell TumorsUrologic Clinics of North America, 1987
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Journal of Clinical Investigation, 1986